/AHCO
AHCO Stock - AdaptHealth Corp.
Healthcare|Medical - DevicesNASDAQ
$9.97-2.54%
$0.26 (-2.54%) • Dec 19
72
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.68
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.49
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+115.0%upside
Target: $21.44
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for AHCO
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$9.87 – $10.07
TARGET (TP)$21.44
STOP LOSS$9.17
RISK/REWARD1:14.3
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.77
52W High$11.63
52W Low$7.11
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $3.26B | $3.20B | $2.97B | $2.45B | $1.06B |
| Gross Profit | $681.09M | $681.77M | $417.43M | $445.61M | $157.79M |
| Gross Margin | 20.9% | 21.3% | 14.1% | 18.2% | 14.9% |
| Operating Income | $263.73M | $-598,401,000 | $190.41M | $225.60M | $71.35M |
| Net Income | $90.42M | $-678,895,000 | $69.32M | $156.18M | $-161,632,000 |
| Net Margin | 2.8% | -21.2% | 2.3% | 6.4% | -15.3% |
| EPS | $0.62 | $-5.32 | $0.52 | $1.12 | $-1.23 |
Company Overview
AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. is headquartered in Plymouth Meeting, Pennsylvania.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
0%
Hold / Neutral
4
80%
Sell / Underperform
1
20%
Analyst Consensus🔴 Bearish
0 Bullish5 Neutral/Bearish
Price Targets
$10
Average Target
↓ 2.1% Downside
Now
$7
Low
$10
Average
$12
High
Based on 5 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| January 8th 2024 | Jefferies | Downgrade | Hold | $8← $14.5 |
| November 8th 2023 | BofA Securities | Downgrade | Underperform | $6.5← $9.5 |
| May 10th 2023 | Deutsche Bank | Downgrade | Hold | $11.3← $28 |
| May 10th 2023 | Stifel | Downgrade | Hold | $11← $18 |
| May 9th 2023 | BofA Securities | Downgrade | Neutral | $12← $21 |
Earnings History & Surprises
AHCOBeat Rate
22%
Last 18 quarters
Avg Surprise
-26.2%
EPS vs Estimate
Beats / Misses
4/12
2 met exactly
Latest EPS
$0.22
Q4 2025
EPS Surprise History
Q1 24
+220.0%
$0.64vs$0.20
Q2 24
-66.7%
$0.02vs$0.06
Q3 24
+10.5%
$0.21vs$0.19
Q4 24
-11.8%
$0.15vs$0.17
Q1 25
+56.0%
$0.39vs$0.25
Q2 25
0.0%
$0.01vs$0.01
Q3 25
-93.3%
$0.01vs$0.15
Q4 25
-8.3%
$0.22vs$0.24
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 4, 2026 | — | — | — | — |
Q1 2026 | Feb 24, 2026 | $0.34 | — | — | — |
Q4 2025 | Nov 4, 2025 | $0.24 | $0.22 | -8.3% | ✗ MISS |
Q3 2025 | Aug 5, 2025 | $0.15 | $0.01 | -93.3% | ✗ MISS |
Q2 2025 | May 6, 2025 | $0.01 | $0.01 | 0.0% | = MET |
Q1 2025 | Feb 25, 2025 | $0.25 | $0.39 | +56.0% | ✓ BEAT |
Q4 2024 | Nov 5, 2024 | $0.17 | $0.15 | -11.8% | ✗ MISS |
Q3 2024 | Aug 6, 2024 | $0.19 | $0.21 | +10.5% | ✓ BEAT |
Q2 2024 | May 7, 2024 | $0.06 | $0.02 | -66.7% | ✗ MISS |
Q1 2024 | Feb 27, 2024 | $0.20 | $0.64 | +220.0% | ✓ BEAT |
Q4 2023 | Nov 7, 2023 | $0.19 | $0.19 | 0.0% | = MET |
Q3 2023 | Aug 8, 2023 | $0.11 | $0.16 | +45.5% | ✓ BEAT |
Q2 2023 | May 9, 2023 | $0.08 | $0.01 | -87.5% | ✗ MISS |
Q1 2023 | Feb 27, 2023 | $0.31 | $0.01 | -96.8% | ✗ MISS |
Q4 2022 | Nov 8, 2022 | $0.31 | $0.11 | -64.5% | ✗ MISS |
Q3 2022 | Aug 9, 2022 | $0.28 | $0.18 | -35.7% | ✗ MISS |
Q2 2022 | May 10, 2022 | $0.21 | $-0.02 | -109.5% | ✗ MISS |
Q1 2022 | Feb 24, 2022 | $0.34 | $0.17 | -50.0% | ✗ MISS |
Q4 2021 | Nov 4, 2021 | $0.34 | $0.20 | -41.2% | ✗ MISS |
Q3 2021 | Aug 5, 2021 | $0.29 | $-0.11 | -137.9% | ✗ MISS |
Latest News
Canaccord Genuity Maintains Buy on AdaptHealth, Raises Price Target to $15
📈 PositiveBenzinga•Nov 6, 2025, 07:55 PM•Also:
AdaptHealth shares are trading higher after the company reported better-than-expected Q3 sales results.
📈 PositiveBenzinga•Nov 4, 2025, 04:46 PM
AdaptHealth Affirms FY2025 Sales Guidance of $3.180B-$3.260B vs $3.225B Est
➖ NeutralBenzinga•Nov 4, 2025, 12:07 PM
AdaptHealth Q3 EPS $0.16 Misses $0.23 Estimate, Sales $820.314M Beat $799.311M Estimate
➖ NeutralBenzinga•Nov 4, 2025, 12:06 PM
Frequently Asked Questions about AHCO
What is AHCO's current stock price?
AdaptHealth Corp. (AHCO) is currently trading at $9.97 per share. The stock has moved -2.54% today.
What is the analyst price target for AHCO?
The average analyst price target for AHCO is $21.44, based on 1 analyst.
What sector is AdaptHealth Corp. in?
AdaptHealth Corp. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the NASDAQ exchange.
What is AHCO's market cap?
AdaptHealth Corp. has a market capitalization of $1.35 billion, making it a small-cap company.
Does AHCO pay dividends?
No, AdaptHealth Corp. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAMPH
Amphastar Pharmaceuticals, Inc.
$26.60
Mkt Cap: $1.2B
BBNX
Beta Bionics, Inc.
$29.25
Mkt Cap: $1.3B
CNMD
CONMED Corporation
$39.95
Mkt Cap: $1.2B
CVAC
CureVac N.V.
$4.16
Mkt Cap: $0.9B
ESTA
Establishment Labs Holdings Inc.
$74.42
Mkt Cap: $2.2B
HCSG
Healthcare Services Group, Inc.
$19.54
Mkt Cap: $1.4B
INMD
InMode Ltd.
$14.36
Mkt Cap: $1.0B
IRMD
IRadimed Corporation
$97.19
Mkt Cap: $1.2B
STAA
STAAR Surgical Company
$25.14
Mkt Cap: $1.2B
UFPT
UFP Technologies, Inc.
$229.40
Mkt Cap: $1.8B
Explore stocks similar to AHCO for comparison